Received May 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Had a seizure 6 days after getting the first shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of seizure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 6 days after receiving Shingles vaccine, the patient experienced seizure (Verbatim: Had a seizure 6 days after getting the first shot) (serious criteria GSK medically significant). The outcome of the seizure was not reported. It was unknown if the reporter considered the seizure to be related to Shingles vaccine. The company considered the seizure to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 01-MAY-2025 This case was reported by a patient via interactive digital media. The patient had a seizure 6 days after getting the first shot. The patient did not get the 2nd shot. The patient would have gotten it if he/she had not had the seizure. The patient would take his/her chances.; Sender's Comments: Seizure is an unlisted event which is considered unrelated to GSK Shingles vaccine.